Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →B grade PMID 42748428
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42765973
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →This retrospective case series reports generally favorable cosmetic and functional outcomes in 11 children with congenital divided eyelid nevi treated by single-stage excision, bilateral advancement flaps, and canthal anchoring, with a few transient minor complications and no reported severe complications.
The reported human outcomes suggest that bilateral advancement flaps with canthal anchoring may provide a useful reconstructive option after excision of congenital divided eyelid nevi; however, superiority, durable safety, and broader applicability remain inferential because the study was small, retrospective, and uncontrolled.
This single-center qualitative study of 12 pediatric-oncology professionals identified terminology, inconsistent initiation criteria, limited pediatric standards, communication gaps, and underrepresentation of nurses in tumor boards as barriers to early pediatric palliative-care integration.
The interviews provide evidence about perceived implementation barriers and facilitators; they support the hypothesis—but do not demonstrate—that guideline-aligned standards, stronger nursing participation, interprofessional training, ethical-reflection forums, and earlier specialist involvement could improve palliative-care integration and potentially quality of life.
The study reports that SA-FGPN, a stability-aware and interpretable deep-learning framework, classified pediatric brain tumors from a 130-sample, 54,676-probe gene-expression dataset with high repeated cross-validation performance and identified stable, functionally enriched transcriptomic features.
Evidence in the record supports transcriptomic tumor classification and feature prioritization, not treatment efficacy; inferentially, if independently and prospectively validated, the framework could improve molecular subtype assignment, support treatment selection, or nominate tumor-associated genes for therapeutic investigation.
In a 25-year single-center retrospective cohort of 194 children with growth hormone deficiency treated with recombinant growth hormone, hypothalamic-pituitary MRI was abnormal in 37.6%, including congenital variants and a small number of craniopharyngiomas, germinomas, and medulloblastomas.
The reported tumor and structural-abnormality findings support MRI and longitudinal endocrine assessment as clinically relevant components of GHD evaluation; by inference, structured surveillance might facilitate earlier recognition of tumors or additional pituitary deficiencies, although this study did not test earlier detection, treatment selection, cancer outcomes, or surveillance benefit.
This mixed-methods observational study found that only 38 of 836 eligible AYA cancer survivors attended a survivorship clinic, with interviews identifying lack of awareness, avoidance, and time constraints as barriers and oncology-team referrals, service information, and telehealth as potential facilitators.
The evidence shows low clinic utilization and participant-reported barriers and facilitators; it is reasonable but untested to hypothesize that systematic oncology-team referrals, clearer communication, and telehealth access could increase survivorship-care uptake and potentially improve management of treatment-related late effects.
In 20 adult patients with craniopharyngioma or CNS germ cell tumor, social participation and physical activity were lower than in 25 healthy participants, and greater apathy was correlated with lower productivity.
The study provides observational evidence linking apathy with reduced productivity; it is reasonable but untested to hypothesize that apathy-focused rehabilitation, structured activity planning, or caregiver-supported engagement could improve participation.
This FAERS disproportionality study identified 9,014 myocarditis reports from 2004–2023, with chemotherapy commonly represented, substantial hospitalization and death reporting, clozapine having the most reports, and phendimetrazine showing the strongest reporting association.
The evidence supports pharmacovigilance signals—not causal drug risks—suggesting that targeted cardiac monitoring of patients receiving drugs with disproportionate myocarditis reporting could potentially enable earlier toxicity detection; pediatric benefit remains inferential because age-specific pediatric results are not provided.
This reply reports Sanger sequencing confirmation of DNAJB1::PRKACA fusion transcripts in several hepatoblastoma and three biliary atresia samples and argues that low transcript levels may escape standard RNA-seq fusion detection.
The supplied evidence supports the presence of low-level DNAJB1::PRKACA transcripts in some patient samples; it is an inference, not demonstrated here, that validated fusion-positive hepatoblastomas could define a biomarker-selected subgroup for fusion-directed treatment or treatment selection.
A nationally representative survey of 1,635 adults in Aotearoa New Zealand found broad public support for government-funded, school-based, regulatory, and affordability-focused skin cancer prevention policies.
The evidence establishes public acceptability—not efficacy—of structural prevention policies; it is reasonable to infer that this support could facilitate implementation of school sun-protection programs and other measures intended to reduce childhood ultraviolet exposure and future skin cancer risk, but no pediatric cancer outcomes were evaluated.
This cross-sectional national audit of 26 Irish acute cancer centres and hospitals found that dedicated cancer physiotherapy provision varied, staffing and funding were major barriers, and paediatric and adolescent services were limited to inpatients.
The audit provides evidence of a paediatric and adolescent outpatient physiotherapy service gap; it can be hypothesized, but is not demonstrated here, that expanding specialized physiotherapy across care settings could improve rehabilitation, symptom management, or treatment tolerance.
A secondary grounded-theory analysis of six focus groups found that physical, psychological, and social changes shape identity among AYA cancer survivors, with sexual and gender minority survivors additionally reporting heteronormative assumptions and disclosure challenges in healthcare.
The study provides qualitative evidence of identity-related and SGM-specific supportive-care needs; it is reasonable—but not tested here—to hypothesize that tailored psychological interventions, peer support, and more inclusive clinical practices could improve psychosocial outcomes.
This narrative review describes diagnostic delays, potentially more advanced or aggressive disease, uncertain benefit from treatment intensification, and substantial psychosocial and fertility-related needs among patients with gastrointestinal cancers diagnosed before age 50, while highlighting limited access to specialized multidisciplinary care.
The review reports unmet care-delivery and supportive-care needs rather than testing a treatment; it is reasonable to hypothesize—but not established by this record—that scalable multidisciplinary programs could improve timely diagnosis, treatment selection, fertility support, psychosocial care, and equity without unnecessary treatment intensification.
